Skip to main content
Home
Knowledge Base
for the National TB Elimination Program - NTEP
x

Main navigation

  • Home +
    • About Us
  • Curriculum +
    • Content view
    • List View
  • Knowledge Map +
    • Knowledge Map Summary
  • Documents
  • Page Library +
    • Content Page Summary
x

YV: TB & TB Epidemiology

  1. Home ›
  2. ›
  3. YV: TB & TB Epidemiology ›
  4. YV: TB & TB Epidemiology
Fullscreen
  • Tuberculosis

    Content

    Figure: Causative agent for Tuberculosis is Bacillus: Mycobacterium tuberculosis (M.tb)

     

    • Tuberculosis (TB) is a communicable disease that is a major cause of ill health.

    • TB is caused by the bacillus Mycobacterium tuberculosis (M.tb)

    • TB disease typically affects the lungs (pulmonary TB) (80%) but can also affect other parts of the body (extra pulmonary TB) (20%)

    • It spreads when people who are sick with TB expel bacteria into the air (for example by coughing, sneezing, shouting or singing)

    • It is one of the top 10 causes of death worldwide and the leading cause of death from a single infectious agent

     

    ​

    Resources

    • Global Tuberculosis Report, 2020; Geneva: World Health Organization, 2020
    • Training Modules (1-4) for Programme Managers and Medical Officers India: Central TB Division, MoHFW, Government of India,July 2020

     

  • Burden of TB in India

    Content

    TB is one of the top burdensome infectious diseases in India. It is estimated that, around 1/4th (26%) of the world's TB cases are in India, translating to about 30 Lakhs new TB cases emerging each year (TB incidence). Against this estimated incidence the National TB Elimination program reported around 19 lakh new and relapse cases in the year 2021.

    An estimated 5 Lakhs deaths occur due to TB each year in the country, translating to about 1 case of TB death every one-two minutes. Compared to this, there are only about 60 thousand deaths due to HIV and about 77 deaths due to Malaria each year.

    TB diagnosis and treatment services although provided free of cost in the public sector, the cost of accessing these services and related loss of wages drive the affected people with poverty (catastrophic costs). TB also has a huge impact on the world's and the country's economy because of loss of workdays (100 million workdays per year).

     

    Assessment

    Question​ Answer 1​ Answer 2​ Answer 3​ Answer 4​ Correct answer​ Correct explanation​ Page id​ Part of Pre-test​ Part of Post-test​
    What is the estimated number of incident TB cases that emerge each year in India? 35 Lakh cases 26 Lakh Cases 26% of the Global Burden 19 Lakh Cases 2 The estimated number of new and relapse (incident) cases in India that emerge each year is about 26 Lakh ​ Yes Yes
    How many cases of deaths are estimated to be caused by TB in India Approximately One death every 2-3 minutes Approximately 5 Lakh deaths 60 Thousand deaths each year 1 and 2 4 In India it is estimated that there is around one death caused due to TB every one to two minutes, translating to about 5Lakh deaths each year in India   Yes Yes

    Resources:

    • *WHO Global TB Report 2021
    • ^Status of National AIDS Response
    • $PIB MOHFW

     

  • TB Causative organism

    Content

    Figure Mycobacterium tuberculosis

     

    TB is caused due to the infection by a bacterium called Mycobacterium tuberculosis.

     

    Figure: Extra-Pulmonary Tuberculosis

     

    It often affects the lungs, and in such cases it is called Pulmonary Tuberculosis. But, it can affect almost any part of the body (except the hair and the nails), in which it is known as Extra-Pulmonary Tuberculosis.

     

     

    Resources:

    • Technical and Operational Guidelines for TB Control in India 2016
  • Determinants of TB Disease

    Content

    Determinants are any characteristics that affect the health of a patient.

    Biological Determinants Behavioral Determinants Socio Economic Determinants Occupational Determinants
    • People living with HIV(PL HIV)
    • History of contact with a case of TB
    • People with underlying medical conditions like Diabetes, Kidney disease, Cancer etc.
    • Existing lung disease
    • Old age
    • Use of tobacco and alcohol
    • Malnutrition
    • Person in contact with TB infected patient
    • Person living in areas with poor ventilation & over crowding
    • Poverty and Malnutrition
    • Homeless
    • Mining work
    • Quarry work(Silicosis)
    • Construction work
    • Migrant worker
    • Daily wagers
  • Vulnerable Population for Tuberculosis

    Content

    TB can affect anyone but it is more prevalent in some communities which are vulnerable to TB disease due to various factors which are mentioned below:

    Increased exposure of TB due to where they live or work

    • prisoners
    • slum dwellers
    • miners
    • hospital visitors
    • healthcare workers

    Limited access to Quality TB services

    • Migrant workers
    • Women in settings with gender disparity,
    • Children
    • Physically challenged
    • Transgender population
    • Tribal and population living in hard to reach areas
    • Refugees or internally displaced people
    • Illegal miners and undocumented migrants

     

    Increased risk because of biological or behavioural factors that compromise immune functions in people who:

    • People who live with HIV
    • have diabetes or silicosis
    • undergo immunosuppressive therapy
    • are undernourished
    • use tobacco
    • suffer from alcohol use disorders.
    • inject drugs 
  • Symptoms of TB Disease

    Content

    Active TB disease has 4 major symptoms (the 4 Symptom complex). Presence of any one of these symptoms without any other reason warrants evaluation for TB. These are:

    Figure: Signs and Symptoms of TB

    People affected with TB may experience other symptoms as well. These may be based on the site that is affected with TB or other more non-specific symptoms of an infection. The physician or doctor would evaluate these symptoms in view of diagnosis of TB.

    Resources:

    • Technical and Operational Guidelines for TB Control in India 2016

     

  • Mode of TB Transmission

    Content

    Tuberculosis is transmitted mainly through the air via droplet nuclei generated when a TB patient coughs or sneezes. 

    It is estimated that every sputum smear-positive patient spreads the infection to 10 – 15 persons annually, if untreated..

    Figure: Transmission of TB bacteria through air via droplet

     

    Resources:

    • Technical and Operational Guidelines for TB Control in India 2016
    • WHO - Fact sheet details on Tuberculosis

    Kindly provide your valuable feedback on the page to the link provided HERE

  • Progression to TB Disease

    Content

    After exposure to infective droplets containing M.TB, only a small proportion gets infected and further progresses to active TB disease.

    • Majority of those that get infected persist in a stage of clinical latency known as TB infection (previously known as Latent TB infection). They do not have TB disease and do not show any symptoms of TB and no evidence of any TB related changes on chest X-ray.
    • A small proportion of those with prior infection may progress to active TB disease due to various environmental/ agent/ host factors.

    Figure: Flow chart for TB disease progression

     

    Resources:

    • Understanding delayed T-Cell Priming, Lung Recruitment, and AirwayLuminal T-Cell Responses in Host defence against Pulmonary Tuberculosis

     

    Kindly provide your valuable feedback on the page to the link provided HERE

  • TB Infection

    Content
    • TB Infection (or previously known as Latent TB infection) is a stage in between uninfected and having active TB. In this stage the person has no symptoms and can only be identified using laboratory tests.

    • The vast majority of infected people may never develop TB disease. However, to achieve TB elimination, it is important to treat TB infection in people at risk of developing active TB disease.

    • It is a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens with no evidence of clinically manifested active TB.

    • There is no single acceptable/reliable test for direct identification of Mycobacterium tuberculosis infection in humans. Tuberculin Skin Test (TST) and Interferon-gamma release assay (IGRA) are commonly used tests for identifying TB infection.

    Resources:

    • Latent Tuberculosis Infection Guideline

    • Guideline for Programmatic Management of Tuberculosis Preventive Treatment in India

     

  • TB Infection Vs Active TB Disease

    Content

      

    TB Infection Active TB Disease
    May not have any signs & symptoms Has sign and symptoms such as cough for more than two weeks, fever, weight loss and blood in sputum
    Has dormant, contained bacteria is the body Has active, multiplying bacteria in the body
    Doesn't spread TB bacteria to others May spread TB bacteria to others
    Chest X-ray usually normal Lesion in Chest X- ray (usually)
    May advance to active TB. It is estimated that the lifetime risk of an individual with TB infection for progression to active TB is 5–10%. Needs treatment for TB disease

    Resources:

    • Technical and Operational Guidelines for TB Control in India 2016
  • Prevention of TB

    Content

    As TB is an airborne infection, TB bacteria are released into the air when someone with infectious TB coughs or sneezes. The risk of infection can be reduced by taking simple precautions:

    Figure: Measures for control and prevention of tuberculosis

    TB Preventive Treatment(TPT) also has a very important role in prevention of TB. Presently, household contacts of sputum-positive TB patients are given TPT upon confirmation of TB infection and ruling our active Tuberculosis.

    Resources:

    • Technical and Operational Guidelines for TB Control in India 2016


     

  • Drug-Sensitive Tuberculosis(DS-TB)

    Content

    What is Drug-Sensitive Tuberculosis (DS-TB)?

    • DSTB is a case where a person is infected with TB bacteria that are susceptible to all first line anti-TB drugs. It means that all of the first line TB drugs will be effective as long as they are taken properly and regularly.

    • This type of TB has the best prognosis and the shortest treatment duration.

    • Patients diagnosed with TB are considered to be DS-TB case, till such time s/he detected with resistance to any anti-TB drugs.

      

    Kindly provide your valuable feedback on the page to the link provided HERE

  • Drug-Resistant Tuberculosis(DR-TB)

    Content

    What is Drug-Resistant Tuberculosis?

    • Drug-Resistant TB occurs when bacteria become resistant to the drugs used to treat TB. This means that the drug can no longer kill the TB bacteria.

    • Multidrug-resistant TB (MDR TB) is a type of DR-TB where TB bacteria is resistant to both Isoniazid and Rifampicin, the two most potent anti-TB drugs.

                                   Figure: High Risk for Drug-Resistant Tuberculosis (DRTB)

    Resources:

    • Guidelines for Programmatic Management of Drug-Resistant Tuberculosis in India, March 2021 
    • WHO Consolidated Guidelines on Tuberculosis: Module 4-Treatment: Drug resistant TB Treatment, 2020
  • TB Treatment Adherence

    Content

    Tuberculosis(TB) is curable if patients are treated with effective, uninterrupted anti-tuberculous treatment. Treatment adherence is critical for curing individual patients, controlling the spread of infection in the community, and minimizing the development of drug resistance.

    Adherence to treatment means that a patient follows the recommended course of treatment by taking all the prescribed medications for the entire length of time, as necessary. In other words, “right dose for the right duration”.

    In Drug Sensitive Tuberculosis(DSTB), a TB patient completes 168 doses of TB treatment and adheres to TB treatment.


     

  • Importance of Treatment adherence

    Content

    Adherence to tuberculosis(TB) treatment is important for promoting individual and public health. Poor adherence to TB treatment results in:

    • More individual suffering and death,
    • Costly treatment as treatment regimens lengthen and
    • Increases the risk for Drug Resistant Tuberculosis

     

    Proper treatment of all forms of TB is critical to reducing individual morbidity and mortality and to interrupting transmission among family and community members.


     

© 2026 Knowledge Base, All rights reserved.

User account menu

  • Log in
⇡